By mentioning a Pfizer drug by name in his State of the Union Address, Biden showed the clear bias this government has for expensive, high-profit drugs while ignoring lower-cost treatments.

Pfizer’s Paxlovid, part of the White House’s ‘test and treat’ plan, cannot be taken by those on certain antidepressants, anti-seizure, anti-psychotic, cholesterol, blood pressure and several other classes of medications.

Despite war in Ukraine bumping COVID-19 from the headlines, the virus continues to spread. Shortly after former President Barack Obama tweeted about his own bout with illness, White House spokesperson Jen Psaki and former Secretary of State Hillary Clinton have also disclosed their infections, ironically even as they continue to promote vaccines. Let’s hope they all recover quickly and only lose their credibility to the disease.

Getting COVID-19 out of the news is a relief for President Biden, who is failing to deliver on his campaign promise to “crush” the virus. The government’s $1.9 trillion COVID relief fund is running out. After House Democrats removed $15 billion for COVID relief from a larger government funding package, the White House is predicting “severe consequences” without additional funding. Meanwhile, the consumer price index showed inflation rising 7.9 percent over the last year, hitting a four-decade high, and the national debt is over $30 trillion.

In his recent op-ed for the Washington Examiner, Dr. Pierre Kory argues that the White House’s National COVID-19 Preparedness Plan needs to adopt a more holistic strategy that includes safe and effective generic treatments along with a public campaign encouraging healthy behaviors:

While early treatment is the best outcome for any illness, prevention is an even better strategy. The White House should take a page out of former First Lady Michelle Obama’s playbook and encourage Americans to eat well, exercise, lose weight and ensure sufficient Vitamin D (and other) stores. These factors demonstrably strengthen natural immunity and have been shown to prevent serious COVID outcomes. Nearly 40 percent of American adults aged 20 and over are obese, meaning millions more people are at higher risk of hospitalization and death from COVID.  


orange prescription bottle lot